Affinity Asset Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Hold |
|
|||||
|
2025
Q1 | $26.5M | Sell |
|
|||||
|
2024
Q4 | $25.5M | Sell |
|
|||||
|
2024
Q3 | $21.2M | Sell |
|
|||||
|
2024
Q2 | $30.8M | Sell |
|
|||||
|
2024
Q1 | $30.7M | Buy |
|
|||||
|
2023
Q4 | $23.1M | Buy |
|
|||||
|
2023
Q3 | $12.4M | Sell |
|
|||||
|
2023
Q2 | $21.4M | Sell |
|
|||||
|
2023
Q1 | $22.5M | Buy |
|
|||||
|
2022
Q4 | $20.3M | Sell |
|
|||||
|
2022
Q3 | $6.5M | Hold |
|
|||||
|
2022
Q2 | $7.16M | Buy |
|
|||||
|
2022
Q1 | $7.36M | Buy |
|
|||||
|
2021
Q4 | $5.51M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $556K | Buy |
|